Phase 2 randomized, double-blind study of IL-17 targeting with secukinumab in atopic dermatitis

Benjamin Ungar, Ana B. Pavel, Randall Li, Grace Kimmel, John Nia, Peter Hashim, Hee Jin Kim, Margot Chima, Anjali S. Vekaria, Yeriel Estrada, Hui Xu, Xiangyu Peng, Giselle K. Singer, Danielle Baum, Yasaman Mansouri, Mark Taliercio, Emma Guttman-Yassky

Research output: Contribution to journalArticlepeer-review

73 Scopus citations
Original languageEnglish
Pages (from-to)394-397
Number of pages4
JournalJournal of Allergy and Clinical Immunology
Issue number1
StatePublished - Jan 2021

Cite this